IMVT-1401-2402: A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP (clinicaltrialsregister.eu) - May 11, 2026 - P1/2 | N=35 | Completed | Sponsor: Immunovant Sciences GmbH | Recruiting ➔ Completed
Trial completion • Pain
|